Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.
Clicks: 240
ID: 102942
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.8
/100
26 views
26 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally and the number is still increasing rapidly. Herein, we presented four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all the four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy.
| Reference Key |
zhang2020treatmentchest
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhang, Bin;Liu, Shuyi;Tan, Tan;Huang, Wenhui;Dong, Yuhao;Chen, Luyan;Chen, Qiuying;Zhang, Lu;Zhong, Qingyang;Zhang, Xiaoping;Zou, Yujian;Zhang, Shuixing; |
| Journal | chest |
| Year | 2020 |
| DOI |
S0012-3692(20)30571-7
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.